[Form 4] Vita Coco Company, Inc. Insider Trading Activity

Rhea-AI Filing Summary

Martin Roper, listed as Director and Chief Executive Officer of Vita Coco Company, Inc. (COCO), reported multiple sales of company common stock under a Rule 10b5-1 trading plan executed on 10/01/2025 and 10/02/2025. The filings show repeated disposals of 5,000-share blocks at weighted average prices in the low $42 range (reported ranges between $41.79 and $42.66). Following the reported 10/01 sale the filing shows 303,897 shares beneficially owned directly; following the 10/02 sale that direct ownership is shown as 298,897. The Form 4 also discloses multiple indirect holdings by related family trusts and a spouse, and reports several non-qualified stock options with exercise prices from $10.178 to $32.78, some fully vested and currently exercisable and others subject to multi-year vesting schedules.

Positive

• Sales executed under a Rule 10b5-1 trading plan, indicating predetermined trade instructions rather than ad-hoc insider trades
• Detailed disclosure of family trust and spouse holdings, improving transparency about indirect beneficial ownership
• Clear option disclosure with exercise prices and vesting schedules provided for all reported awards

Negative

• Insider sold multiple blocks of shares on 10/01/2025 and 10/02/2025, reducing direct beneficial ownership from 303,897 to 298,897
• Weighted average sale prices clustered in the low $42 range, which may be perceived by some investors as material insider selling activity

Insights

Corporate Governance Expert

CEO/director sales under a 10b5-1 plan, with disclosed family trust holdings.

The Form 4 shows Martin Roper executed multiple sales of 5,000-share blocks on 10/01/2025 and 10/02/2025 under a Rule 10b5-1 plan, with weighted average prices in the low $42 range. That establishes the trades were pre-planned rather than opportunistic.

The filing also discloses indirect holdings through the Christopher G. Roper Exempt Family Trust, the Peter S. Roper Exempt Family Trust, the Thomas L. Roper Exempt Family Trust, and a spouse, which is important for understanding total insider-linked ownership reported on the form.

Equity Compensation & Markets Expert

Significant option positions disclosed; several options are fully vested and exercisable.

Table II lists multiple Non-Qualified Stock Options with exercise prices from $10.178 to $32.78. Footnotes indicate the $10.178 options are fully vested and currently exercisable and other grants vest over specified multi‑year schedules.

The existence of large option grants and current exercisability can affect future share supply if exercised and sold; the Form 4 explicitly quantifies the underlying share counts for each option award.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

1. Name and Address of Reporting Person^*

Roper Martin

(Last) (First) (Middle)

111 5TH AVENUE

2ND FLOOR

(Street)

NEW YORK NY 10003

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Vita Coco Company, Inc. [ COCO ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Executive Officer

3. Date of Earliest Transaction (Month/Day/Year)
10/01/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	10/01/2025		S(1)		5,000	D	$42.457(2)	303,897	D
Common Stock	10/02/2025		S(1)		5,000	D	$42.067(3)	298,897	D
Common Stock	10/01/2025		S(1)		5,000	D	$42.463(4)	238,406	I	by Chris Roper FT(5)
Common Stock	10/02/2025		S(1)		5,000	D	$42.049(6)	233,406	I	by Chris Roper FT(5)
Common Stock	10/01/2025		S(1)		5,000	D	$42.458(7)	237,515	I	by Peter Roper FT(8)
Common Stock	10/02/2025		S(1)		5,000	D	$42.066(9)	232,515	I	by Peter Roper FT(8)
Common Stock	10/01/2025		S(1)		5,000	D	$42.467(10)	238,531	I	by Thomas Roper FT(11)
Common Stock	10/02/2025		S(1)		5,000	D	$42.069(12)	233,531	I	by Thomas Roper FT(11)
Common Stock								61,200	I	by Spouse

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Non-Qualified Stock Option (right to buy)	$10.178							(13)	09/19/2029	Common Stock	579,670		579,670	D
Non-Qualified Stock Option (right to buy)	$10.178							(14)	01/11/2031	Common Stock	40,950		40,950	D
Non-Qualified Stock Option (right to buy)	$15							(15)	10/21/2031	Common Stock	298,507		298,507	D
Non-Qualified Stock Option (right to buy)	$16.91							(16)	03/10/2033	Common Stock	46,875		46,875	D
Non-Qualified Stock Option (right to buy)	$26.18							(17)	03/04/2034	Common Stock	62,743		62,743	D
Non-Qualified Stock Option (right to buy)	$32.78							(18)	03/03/2035	Common Stock	70,715		70,715	D

Explanation of Responses:

1. The sales of shares of common stock reported were effected pursuant to a Rule 10b5-1 trading plan.

2. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $42.23 to $42.66, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

3. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $41.79 to $42.53, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

4. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $42.23 to $42.66, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

5. These shares are held by the Christopher G. Roper Exempt Family Trust.

6. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $41.79 to $42.53, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

7. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $42.23 to $42.66, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

8. These shares are held by the Peter S. Roper Exempt Family Trust.

9. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $41.79 to $42.53, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

10. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $42.23 to $42.66, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

11. These shares are held by the Thomas L. Roper Exempt Family Trust.

12. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $41.79 to $42.53, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

13. The stock option is fully vested and currently exercisable.

14. The stock option is fully vested and currently exercisable.

15. The stock option vests in four equal annual installments beginning on November 27, 2022.

16. The stock option vests in four equal annual installments beginning on March 10, 2024.

17. The stock option vests in four equal annual installments beginning on March 4, 2025.

18. The Stock Option vests in four equal annual installments beginning in March 3, 2026.

	By: Alison Klein, Attorney-in-Fact For: Martin Roper	10/03/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Martin Roper (COCO) report on this Form 4?

Martin Roper reported multiple sales of common stock on 10/01/2025 and 10/02/2025 under a Rule 10b5-1 trading plan, in 5,000-share blocks at weighted average prices in the low $42 range.

How many shares did Martin Roper own after these transactions?

The filing shows 303,897 shares held directly after the 10/01/2025 sale and 298,897 held directly after the 10/02/2025 sale.

Are any of Martin Roper's stock options exercisable now?

Yes; the Form 4 discloses Non-Qualified Stock Options at an exercise price of $10.178 that are fully vested and currently exercisable, and other option grants with specified vesting schedules.

Did the Form 4 disclose indirect holdings by family trusts?

Yes; the filing identifies shares held indirectly by the Christopher G. Roper Exempt Family Trust, Peter S. Roper Exempt Family Trust, Thomas L. Roper Exempt Family Trust, and a spouse.

Were the sale prices single prices or ranges?

The filing reports weighted average prices and specifies the sales occurred across price ranges between $41.79 and $42.66.